RECIST revisited: A review of validation studies on tumour assessment

This publication has 50 references indexed in Scilit:

• The Progress and Promise of Molecular Imaging Probes in Oncologic Drug Development
  Clinical Cancer Research, 2005
• Assessment of the value of confirming responses in clinical trials in oncology
  European Journal Of Cancer, 2005
• RECIST vs. WHO: Prospective comparison of response criteria in an EORTC phase II clinical trial investigating ET-743 in advanced soft tissue sarcoma
  European Journal Of Cancer, 2005
• CT, RECIST, and malignant pleural mesothelioma
  Lung Cancer, 2005
• Limitations with the response evaluation criteria in solid tumors (RECIST) guidance in disseminated pediatric malignancy
  Pediatric Blood & Cancer, 2005
• Should CA-125 Response Criteria Be Preferred to Response Evaluation Criteria in Solid Tumors (RECIST) for Prognostication During Second-Line Chemotherapy of Ovarian Carcinoma?
  Journal of Clinical Oncology, 2004
• Staging and response to therapy of malignant pleural mesothelioma
  Lung Cancer, 2004
• Comparison of unidimensional and bidimensional measurements in metastatic non-small cell lung cancer
  British Journal of Cancer, 2002
• New Guidelines to Evaluate the Response to Treatment in Solid Tumors
  JNCI Journal of the National Cancer Institute, 2000
• Selection of large and objectively measurable target lesions in EORTC phase II trials: Impact on recruitment and response rate
  European Journal Of Cancer, 1993